Written information material and availability of sexual health care for men experiencing sexual dysfunction after prostate cancer treatment: An evaluation of Dutch urology and radiotherapy departments

2016 ◽  
Vol 26 (2) ◽  
pp. e12629 ◽  
Author(s):  
L.A. Grondhuis Palacios ◽  
E.M. Krouwel ◽  
M. Duijn ◽  
B.L. den Oudsten ◽  
M.E.M. den Ouden ◽  
...  
BMC Urology ◽  
2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Jeffrey A. Albaugh ◽  
Nat Sufrin ◽  
Brittany R. Lapin ◽  
Jacqueline Petkewicz ◽  
Sandi Tenfelde

2019 ◽  
Vol 7 (12) ◽  
pp. 109
Author(s):  
Travis P. Green ◽  
Jose Saavedra-Belaunde ◽  
Run Wang

The majority of sexual health research has focused on erectile dysfunction following prostate cancer treatment. Ejaculatory and orgasmic dysfunction are significant side effects following the treatment of prostate cancer. Orgasmic dysfunction covers a range of issues including premature ejaculation, anorgasmia, dysorgasmia, and climacturia. This review provides an overview of prevalence and management options to deal with orgasmic dysfunction. A Medline Pubmed search was used to identify articles relating to these problems. We found that orgasmic dysfunction has a very large impact on patients’ lives following prostate cancer treatment and there are ways for physicians to treat it. Management of patients’ sexual health should be focused not only on erectile dysfunction, but on orgasmic dysfunction as well in order to ensure a healthy sexual life for patients and their partners.


2018 ◽  
Vol 26 (12) ◽  
pp. 4169-4176 ◽  
Author(s):  
Lorena A. Grondhuis Palacios ◽  
Esmée M. Krouwel ◽  
Brenda L. den Oudsten ◽  
Marjolein E. M. den Ouden ◽  
Gert Jan Kloens ◽  
...  

2016 ◽  
Vol 39 (3) ◽  
pp. 276-279 ◽  
Author(s):  
Tammy Z. Movsas ◽  
Raphael Yechieli ◽  
Benjamin Movsas ◽  
May Darwish-Yassine

2018 ◽  
Vol 12 (6) ◽  
pp. 2076-2088 ◽  
Author(s):  
Obrey Alexis ◽  
Aaron James Worsley

Studies suggest that gay and bisexual men are affected by the psychological aspects of prostate cancer treatment differently than that of heterosexual men; however the data have not yet been synthesized. The focus of this meta-synthesis is to explore gay and bisexual men’s experiences of prostate cancer posttreatment. Empirical research published in peer reviewed journals between January 1990 and January 2018 were identified in six databases: CINAHL, Cochrane, Medline, PsycINFO, PubMed, and Web of Science. Titles and abstracts were checked by two reviewers. The six studies that met the inclusion criteria were selected and reviewed for quality and the extracted data were then synthesized. The main themes that emerged were sexual impact, physical and psychological difficulties, challenges to intimacy, and support mechanisms. Gay and bisexual men can have specific sexual roles and developing prostate cancer and undergoing treatment may compromise their ability to perform their sexual role. The needs of heterosexual men were perceived to be accommodated more often than that of gay and bisexual men because of engrained heteronormativity in the health-care system. The review suggests that more support groups specifically for gay and bisexual men should be established, while urologists should cater to the sexual and masculine implications of treatment, and not frame problems for gay and bisexual men in heterosexual terms. By failing to address the salient needs and concerns of gay and bisexual men, health-care professionals are reinforcing invisibility and marginalization of gay and bisexual men with prostate cancer.


2017 ◽  
Vol 27 (4) ◽  
pp. 354-359 ◽  
Author(s):  
Gaby F. van Ek ◽  
Esmée M. Krouwel ◽  
Els van der Veen ◽  
Melianthe P. J. Nicolai ◽  
Jan Ringers ◽  
...  

Introduction: Sexual dysfunction (SD) is a common problem in chronic kidney disease (CKD) and endures in 50% of patients after kidney transplantation (KTx), diminishing patients’ expectations of life after KTx. Unfortunately, SD is often ignored by renal care providers. Research questions as part of a research project among all renal care providers, transplant surgeons’ perspectives were obtained on sexual health care for KTx recipients, including their opinion on who should be accountable for this care. In addition, surgeons’ practice and knowledge regarding SD were evaluated. Design: A 39-item questionnaire was sent to all Dutch surgeons and residents specialized in KTx (n = 47). Results: Response was 63.8%. None of the respondents discussed SD with their patients, before or after surgery. Most important barrier was that surgeons do not feel accountable for it (73.9%); 91.7% thought this accountability should lie with the nephrologist. Another barrier was insufficient knowledge (39.1%). In 75% of the respondents, (almost) no knowledge regarding SD was present and 87.5% noticed education on SD was insufficient during residence training. Discussion: Dutch renal transplant surgeons rarely discuss SD with their patients with CKD, as they do not feel accountable for it; this accountability was appointed to the nephrologist. Knowledge and education regarding SD were found insufficient in enabling surgeons and for some it reflects in barriers toward discussing SD. Results emphasize that accountability for providing sexual health care to patients with CKD should lie elsewhere; however, surgeons could briefly provide information on sexual health after KTx, so unfulfilled expectations may be prevented.


Sign in / Sign up

Export Citation Format

Share Document